Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy
Main Authors: | Porcelli, Letizia, Guida, Gabriella, Quatrale, Anna E, Cocco, Tiziana, Sidella, Letizia, Maida, Immacolata, Iacobazzi, Rosa M, Ferretta, Anna, Stolfa, Diana A, Strippoli, Sabino, Guida, Stefania, Tommasi, Stefania, Guida, Michele, Azzariti, Amalia |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2015
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4314759/ |
Similar Items
-
Barasertib: a novel approach for the treatment of metastatic melanoma
by: Azzariti, Amalia, et al.
Published: (2014) -
The relevance of BRAF G469A mutation in determining the response to therapy in metastatic melanoma
by: Porcelli, Letizia, et al.
Published: (2015) -
The mitochondrial master regulator gene PGC1alpha in novel sporadic melanoma cell lines: correlations with BRAF mutational status
by: Guida, Gabriella, et al.
Published: (2014) -
Proteomic Profile and In Silico Analysis in Metastatic Melanoma with and without BRAF Mutation
by: Garrisi, Vito Michele, et al.
Published: (2014) -
microRNAs and next generation sequencing for the prognosis of the metastatic melanoma
by: Pinto, Rosamaria, et al.
Published: (2015)